Trial reportObesity surgery2018
Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 Patients.
Trial report in Obesity surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Bariatric Arterial Embolization for Morbid Obesity
EMbolisation Bariatrique de l'ARcade Gastro-épiploïque Chez Les Patients Obèses
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.
- Left gastric artery embolization for obesity treatment: a systematic review and meta-analysis of human and animal studies.Abdominal radiology (New York) · 2021Pooled it
- Weight Loss after Left Gastric Artery Embolization: A Systematic Review and Meta-Analysis.Journal of vascular and interventional radiology : JVIR · 2019Pooled it
- An ambulatory, vascular surgery office-based approach to bariatric artery embolization.Journal of vascular surgery cases and innovative techniques · 2026Article
- Establishing a multidisciplinary bariatric arterial embolization program: A two-year clinical experience.Obesity pillars · 2025Article
- Review
- Computed tomography assessment of the gastric arterial anatomy for embolisation treatment of obesity.CVIR endovascular · 2025Article
- N-Butyl-2-Cyanoacrylate versus Microspheres on Weight Change and Ghrelin Expressions in Swine Bariatric Embolization Model.CVIR endovascular · 2025Article
- Gastric transcatheter chemoembolization combined with systemic chemotherapy vs. systemic chemotherapy alone for patients with advanced gastric cardiac cancer presenting with dysphagia: A case control study.Oncology letters · 2024Article
- Adding Short to Left Gastric Artery Embolization for the Treatment of Obesity: Safety and Effectiveness.Cardiovascular and interventional radiology · 2024Article
- Obesity: An Overview for the Interventional Radiologist.Seminars in interventional radiology · 2024Review
- EMBIO trial study protocol: left gastric artery embolisation for weight loss in patients living with obesity with a BMI 35-50 kg/mBMJ open · 2023Article
- Interventional metabology: A review of bariatric arterial embolization and endovascular denervation for treating metabolic disorders.Journal of diabetes · 2023Review
- Bariatric arterial embolization in patients with body mass index ranging from 25 to 40 kg/mJournal of cardiovascular and thoracic research · 2023Review
- Bariatric Artery Embolization for Obese Patients. An Up-to-Date Review.Journal of the Belgian Society of Radiology · 2023Article
- Weight Loss and Gastrointestinal Hormone Variation Caused by Gastric Artery Embolization: An Updated Analysis Study.Frontiers in endocrinology · 2022Review
- Identifying the Ideal Target Vessel Size for Bariatric Embolization: Histologic Analysis of Swine and Human Gastric Fundi.Journal of vascular and interventional radiology : JVIR · 2022Article
- Endovascular Bariatric Surgery as Novel Minimally Invasive Technique for Weight Management in the Morbidly Obese: Review of the Literature.Nutrients · 2021Review
- Bariatric Arterial Embolization with Calibrated Radiopaque Microspheres and an Antireflux Catheter Suppresses Weight Gain and Appetite-Stimulating Hormones in Swine.Journal of vascular and interventional radiology : JVIR · 2020Article
- Gastric artery embolization: studying the effects of catheter type and injection method on microsphere distributions within a benchtop arterial model.Biomedical engineering online · 2020Article
- Review
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
purposeThe purpose of this study is to investigate the safety and 9-month effectiveness of transcatheter left gastric artery embolization (LGAE) for treating patients with obesity. MATERIALS AND
methodsThe protocol of this study was approved by the Institutional Ethics Review Board. Five obese patients (3 men and 2 women) with mean weight of 102.0 ± 16.19 kg (range, 82.1-125.5 kg) and mean body mass index (BMI) of 38.1 kg/m
resultsLGAE was successfully performed in all patients. A superficial linear ulceration below the cardia was seen in 1 patient 3 days after LGAE and healed within 30 days. No other serious AEs (grade III or above) occurred. Average body weight loss at 3, 6, and 9 months was 8.28 ± 7.3 kg (p = 0.074), 10.42 ± 8.21 kg (p = 0.047), and 12.9 ± 14.66 kg (p = 0.121), respectively. The level of serum ghrelin decreased by 40.83% (p = 0.009), 31.94% (p = 0.107), and 24.82% (p = 0.151) at 3, 6, and 9 months after LGAE, respectively. There was minimal reduction of leptin levels at 3 and 6 months following LGAE (decreased by 0.26%, p = 0.929, and 4.33%, p = 0.427, respectively), but it declined obviously 9 months after LGAE (decreased by 11.22%, p = 0.295). Both waist circumference and waist-to-height ratio decreased after LGAE. MRI showed the area of subcutaneous adipose tissue decreased from the baseline of 400.90 ± 79.25 to 320.36 ± 68.06 cm
conclusionsOur study with 9-month data in 5 patients indicates that bariatric embolization of the LGA is a safe and may be a promising strategy to suppress the production of ghrelin and results in weight loss and abdominal fat reduction.
trial registrationClinicalTrials.gov (NCT02786108).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.